| ID | 2027 |
|---|
| No | 2027 |
|---|
| Brand Name | ATORIN 40 |
|---|
| Ingredients | ATORVASTATIN CALCIUM TRIHYDRATE 43.280 MG EQ.TO ATORVASTATIN 40 MG |
|---|
| Dosage Form | FILM-COATED TABLETS |
|---|
| Primary Packaging | BLISTERPACK |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | 10 TABS/BLIST., 10 BLISTS/BOX |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | HYPERCHOLESTEROLAEMIA, HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA, HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA OR COMBINED (MIXED) HYPERLIPIDAEMIA IN PATIENTS WHO HAVE NOT RESPONDED ADEQUATELY TO DIET AND OTHER APPROPRIATE MEASURES |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | OFF-WHITE, CIRCULAR, BICONVEX, FILM COATED TABLETS HAVING SCORELINE ON ONE SIDE AND PLAIN ON OTHER SIDES |
|---|
| Note | |
|---|
| License Owner | PALAMY PHARMA CO., LTD |
|---|
| Manufacturer | MEDLEY PHARMACEUTICALS LTD |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 11 I 5648/23 |
|---|
| FDD Registration Date | 23/11/2023 |
|---|
| Expiry Date | 22/11/2026 |
|---|
